SK pharmteco specializes in the commercial and clinical production of APIs, Advanced Intermediates, Registered Starting Materials, and Key Building Blocks. Our offering includes process R&D, analytical method development and stability, scale-up and optimization, validation and commercial production.

Our global operations include 6 cGMP manufacturing and development facilities across the United States, Korea, and Ireland. We also operate a dedicated analytical services facility.

SK pharmteco is a leader in operational excellence and continuous improvement. Our highly skilled team delivers innovative solutions utilizing advanced technologies:

• Energetic Chemistry
• Continuous Flow Processing
• Chromatography: Simulated Moving Bed (SMB) & Batch 
• High Potency (Up to 4 m3 scale & Down to 10 ng/m³ containment) 
• Controlled Substances (Schedule II-V Manufacturing) 
• Particle Engineering

We provide PAI and full regulatory support as well as complete confidentiality. We have a strong record of environmental, health, and safety performance. All our plants have been successfully audited by global regulatory agencies including the FDA (US), EMA (Europe), PMDA (Japan), and MFDS (Korea). 

With a strong technology toolbox and ~1,000 m³ (~265,000 gal) of global capacity, we have the capability and capacity to support your needs across the full lifecycle.